Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States
PaperCitations, authors & open-access status
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 79 citations, 2022 year and green oa status.
79
Citations
2022
Year
green
OA Status